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 Abstract    
Objectives: The aim of the study was to assess fertility in patients diagnosed with ectopic pregnancy and treated 
with methotrexate, as well as safety and eﬃcacy of conservative treatment. Also, risk factors of recurrent ectopic 
pregnancies were determined. 
Material and methods: The study included 86 female patients with ectopic pregnancy, hospitalized and treated in 
the clinic of Gynecological Endocrinology, UJCM, Cracow, between 2007 and 2011. A total of 73 patients received 
a single dose of MTX in the amount of 50mg/m2 of body surface area. Serum b-hCG concentration was measured 
on days 4 and 7. The treatment was considered successful when b-hCG concentrations dropped to less than 
0.2mIU/ml without surgery. 
Results: Among 34 patients on follow-up, 8 (23.5%) did not attempt to conceive again, whereas 26 patients 
declared their wish to conceive again. The attempt proved to be successful in case of 16 women (61.53%), and 
they gave birth to healthy children. Average time to pregnancy was 14.9 months (SD±10.9). The ﬁrst pregnancy 
occurred after 6 months and the last after 35 months. No congenital birth defects were found in the newborns. 
Conclusions: Systemic, conservative treatment with methotrexate is an eﬀective and safe way of managing ectopic 
pregnancy, even in cases with higher b-hCG concentrations. Most patients can be successfully treated without 
surgery, thus they may even be treated in outpatient settings. High fertility can be maintained and is independent of 
the skills of the operators and access to laparoscopic techniques. Conservative treatment does not increase the risk 
of recurrent ectopic pregnancy but should be oﬀered in wards that provide 24-hour surgical care. 
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Introduction
7KHIUHTXHQF\RIHFWRSLFSUHJQDQFLHVKDVEHHQRQWKHULVH
The Center for Disease Control and Prevention &'&HVWLPDWHG
WKDW LQRIDOOSUHJQDQFLHVZHUHHFWRSLF&XUUHQWO\
&'& UHSRUWV WKH SHUFHQWDJH WR KDYH ULVHQ WR  >@
)XUWKHUPRUHWKH\UHSRUWDIROGLQFUHDVHLQHFWRSLFSUHJQDQFLHV
IURPFDVHVLQWRFDVHVLQUHODWHGWR
ZLGHVSUHDG DFFHVV WR DVVLVWHG UHSURGXFWLYH WHFKQRORJLHV $57
>@ JUHDWHU SUHYDOHQFH RI VH[XDOO\ WUDQVPLWWHG GLVHDVHV DQG
LQFUHDVHGLQFLGHQFHRISHOYLFLQÀDPPDWRU\GLVHDVHV3,'>@
±HVSHFLDOO\GXHWR&hlamydia trachomatisLQIHFWLRQV>@
8QWLO WKH HQG RI WKH V ODSDURVFRS\ KDV UHPDLQHG WKH
PDLQ GLDJQRVWLF WRRO IRU HFWRSLF SUHJQDQF\ ,Q WKH ODVW GHFDGH
WKHGHYHORSPHQWRIXOWUDVRQRJUDSK\KDVDOORZHGLPSURYHPHQWV
LQ WKH GLDJQRVLV ZLWK VXI¿FLHQW VHQVLWLYLW\ DQG VSHFL¿FLW\ RI
LQFRUUHFWO\LPSODQWHGHPEU\RV7KHVHQVLWLYLW\DQGVSHFL¿FLW\RI
DVLQJOHWUDQVYDJLQDOXOWUDVRQRJUDSK\WHVW796DUH
&, ±  DQG  &, ±  UHVSHFWLYHO\
>@,WLVHVWLPDWHGWKDWRIHFWRSLFSUHJQDQFLHVDSSHDUDVD




DQ\ W\SH RI HFWRSLF SUHJQDQF\ ZKHUHDV ODSDURVFRS\ RQO\ KDV
D UROH LQFDVHRI WUHDWPHQW LQWHUYHQWLRQ >@7KHUHDOVRH[LVWVD
VPDOO JURXS RI ZRPHQ ZLWK D SRVLWLYH SUHJQDQF\ WHVW DQG DQ
XQFKDUDFWHULVWLFLPDJHLQ796WHVWLQJGHVFULEHGLQWKHOLWHUDWXUH
DV38/3UHJQDQF\RI8QNQRZQ/RFDWLRQ










FRPSDUHG WR WKH SK\VLRORJLFDO GRXEOLQJ ZLWKLQ  KRXUV LQ













WXEH SUHJQDQF\ XVLQJ PHWKRWUH[DWH 07; >@ EHJLQQLQJ
DQ HUD RI FRQVHUYDWLYHPDQDJHPHQW0HWKRWUH[DWH D IROLF DFLG
DQWDJRQLVW GLVUXSWV SURSHU'1$ V\QWKHVLV WKXV LQKLELWLQJ FHOO
SUROLIHUDWLRQ7URSKREODVWLF WLVVXH LV HVSHFLDOO\ VHQVLWLYH WR WKH




DUH XVHG 'XH WR KLJK FRVWV RI KRVSLWDOL]DWLRQ D EHQH¿W ZDV
GHPRQVWUDWHG LQ SDWLHQWV ZLWK FRQVHUYDWLYH 07; WUHDWPHQW LQ
D VFKHPHRIPXOWLSOHGRVHVZKHUHEK&*FRQFHQWUDWLRQVZHUH
P,8PO >@ ,Q FRQWUDVW WR WKLV VFKHPH DSSOLFDWLRQ RI
DVLQJOHGRVH LQ WKHDPRXQWRIPJPRIERG\VXUIDFHDUHD
FRQWULEXWHG WR WKH UHGXFWLRQ RI WUHDWPHQW FRVWV E\ VKRUWHQLQJ
WKH GXUDWLRQ RI KRVSLWDOL]DWLRQ ZKLFK DOVR MXVWL¿HV WKH XVH RI
FRQVHUYDWLYHWUHDWPHQWLQKLJKHUEK&*FRQFHQWUDWLRQV6SHFLDO
 Streszczenie
Cel pracy: Badanie miało na celu ocenę  płodności pacjentek ze zdiagnozowaną ciążą pozamaciczną leczonych 
metotreksatem, skuteczność i bezpieczeństwo leczenia zachowawczego oraz poszukiwanie czynników ryzyka 
powtórnej ciąży pozamacicznej. 
Materiał i metody: 86 pacjentek ze zdiagnozowaną ciążą pozamaciczną było objętych leczeniem w Klinice 
Endokrynologii Ginekologicznej UJCM w Krakowie od 2007 do 2011 roku. Po zakwaliﬁkowaniu u 73 pacjentek 
zastosowano terapię pojedynczej dawki metotreksatu w ilości 50 mg/m2 powierzchni ciała. Kolejno oceniano 
stężenia b-hCG w surowicy krwi w dniu czwartym i siódmym terapii. Za sukces terapeutyczny uznawano obniżenie 
wartości b-hCG poniżej 0,2 mIU/ml bez konieczności wykonania zabiegu operacyjnego. 
Wyniki: Pośród 34 pacjentek z przebywających w opiece przyklinicznej, 8 (23,5%) nie zdecydowało się na 
kolejną ciążę. 26 pacjentek zdeklarowało plany reprodukcyjne, 16 (61,53%) z nich urodziło zdrowe dzieci. Średni 
czas do uzyskania ciąży wynosił 14,9 (SD 10,9) miesiąca. Pierwsza ciąża wystąpiła po 6 miesiącach a ostatnia 
obserwowana po 35 miesiącach. Nie zaobserwowano żadnych wad wrodzonych u urodzonych dzieci. 
Wnioski: Systemowe leczenie zachowawcze metotreksatem jest terapią skuteczną i bezpieczną nawet przy 
wyższych wartościach b-hCG niż 3500 mIU/ml. Umożliwia wyleczenie większości pacjentek bez konieczności 
wykonywania zabiegu operacyjnego, nawet w trybie ambulatoryjnym. Pozwala na utrzymanie wysokiej płodności 
niezależnie od umiejętności operatora i dostępności technik laparoskopowych. Leczenie zachowawcze nie 
zwiększa ryzyka rozwoju ponownie ciąży pozamacicznej.
 Słowa kluczowe: FLąĪD HNWRSRZD / PHWRWUHNVDW / SáRGQRĞü / leczenie zachowawcze /
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DWWHQWLRQ LVJLYHQ WR WKH IDFW WKDW WKH WUHDWPHQWPD\EHXVHG LQ
RXWSDWLHQWSUDFWLFHV>@07;JLYHQORFDOO\ERWKXQGHU796DV
ZHOODVODSDURVFRSLFFRQWURO>@GLGQRWGHPRQVWUDWHVLJQL¿FDQW
GLIIHUHQFHV DV FRPSDUHG WR LQWUDPXVFXODU DGPLQLVWUDWLRQ 7KH




EHHQREVHUYHG >   @0RUH LPSRUWDQWO\ QRQHJDWLYH
HIIHFW RQ WKH RYDULDQ UHVHUYH KDV EHHQ QRWHG HLWKHU >@ 7KH
PRVW FRPPRQ HWLRORJ\ RI HFWRSLF SUHJQDQF\ LV FRQVLGHUHG WR
EH WKH FOLQLFDO RU VXEFOLQLFDO LQÀDPPDWLRQ RI WKH IDOORSLDQ
WXEHV SRVVLEO\ OHDGLQJ WR LUUHYHUVLEOH DQG ELODWHUDO GDPDJH
RI WKHLU IXQFWLRQ &RQVHTXHQWO\ WKLV UHVXOWV LQ UHFXUUHQFHV RI
LQFRUUHFWO\ LPSODQWHG SUHJQDQFLHV RU GLI¿FXOWLHV WR FRQFHLYH




7KH WLPH SHULRG RI FRPSOHWH H[FUHWLRQ RI07; IURP WKH
ERG\LV±PRQWKV>@7KHIDFWWKDW07;WKHUDS\LVVDIH
IRU IXWXUH RIIVSULQJ LV SDUWLFXODUO\ QRWHZRUWK\ ,Q UHWURVSHFWLYH
VWXGLHVQRGLIIHUHQFHVZHUHGHPRQVWUDWHGLQWKHIUHTXHQFLHVRI







DVVHVV WKHVDIHW\DQGHI¿FDF\RIFRQVHUYDWLYH WUHDWPHQWDQG WR
GHWHUPLQHWKHULVNIDFWRUVRIUHFXUUHQWHFWRSLFSUHJQDQFLHV
Material and methods
$ WRWDO RI  IHPDOH SDWLHQWV GLDJQRVHG ZLWK DQ HFWRSLF
SUHJQDQF\ ZHUH KRVSLWDOL]HG DQG WUHDWHG LQ WKH FOLQLF RI
*\QHFRORJLFDO (QGRFULQRORJ\ 8-&0 &UDFRZ EHWZHHQ 
DQG  7KH GLDJQRVLV ZDV HVWDEOLVKHG RQ WKH EDVLV RI DQ
DEQRUPDOLQFUHDVHLQEK&*FRQFHQWUDWLRQVDQGXOWUDVRQRJUDSKLF
796 FRQ¿UPDWLRQ RI FKDQJHV LQ WKH SDUDRYDULDQ UHJLRQZLWK
WKHDLGRIWKH*(9ROXVRQ([SHUWRURQWKHEDVLVRIEK&*





FDYLW\([FOXGLQJ FULWHULDZHUH KHPRG\QDPLF LQVWDELOLW\ VLJQV
RI SHULWRQLWLV KHWHURWRSLF SUHJQDQF\ FRQWUDLQGLFDWLRQV WR
DGPLQLVWHULQJPHWKRWUH[DWHHJOHXNRSHQLDWKURPERF\WRSHQLD
HOHYDWHG OLYHU HQ]\PHV RU ELRFKHPLFDO LQGLFDWRUV RI UHQDO
LQVXI¿FLHQF\$IWHUREWDLQLQJZULWWHQFRQVHQWIRU WKHSURSRVHG
WUHDWPHQW SODQ WKH SDWLHQWV UHFHLYHG D VLQJOH GRVH RI07; LQ
WKH DPRXQW RI PJP RI ERG\ VXUIDFH DUHD 6XEVHTXHQWO\












LQ ZKRP EK&* FRQFHQWUDWLRQV GHFUHDVHG E\ OHVV WKDQ 
UHPDLQHG FRQVWDQW RU LQFUHDVHG EHWZHHQ GD\V  DQG  DIWHU
LQLWLDWLQJ WKH ¿UVW GRVH 6XEVHTXHQW GRVHV ZHUH DGPLQLVWHUHG
XQWLO D VDWLVIDFWRU\ GHFUHDVH LQ VHUXP EK&* FRQFHQWUDWLRQ
ZDVREWDLQHGRU VLJQVRIDGYHUVHHIIHFWVGXH WR WKHPHGLFDWLRQ
DSSHDUHG 7KH PD[LPDO GRVH RI07; ZDV PJ WKURXJKRXW
WKH FRXUVH RI WKH WUHDWPHQW DQG WKH WUHDWPHQW UHJLPHQ ZDV LQ
FRPSOLDQFH ZLWK WKH JXLGHOLQHV IRU LQLWLDWLQJ DQG ZLWKGUDZLQJ
WKHPHGLFDWLRQ3DWLHQWVZHUHLQVWUXFWHGWRDWWHQGUHJXODUIROORZ
XSYLVLWVDWWKHRXWSDWLHQWFOLQLFDQGPRQWKVDIWHU
WUHDWPHQW FRPSOHWLRQ HVSHFLDOO\ LQ FDVHVZKHQ WKH\ZLVKHG WR
FRQFHLYHDJDLQ
7KH WUHDWPHQW ZDV FRQVLGHUHG VXFFHVVIXO ZKHQ EK&*
FRQFHQWUDWLRQV GURSSHG WR OHVV WKDQ P,8PO DIWHU LQLWLDWLQJ
FRQVHUYDWLYHWKHUDS\ZLWKRXWWKHQHHGRIVXUJLFDOLQWHUYHQWLRQ
,QFDVHVRIREVHUYDWLRQ ORVV LH WKHSDWLHQWGLGQRWDSSHDU
DWWKHRXWSDWLHQWFOLQLFDQGPRQWKVDIWHUWUHDWPHQW
FRPSOHWLRQ WHOHSKRQH FRQWDFWZDVPDGH LQ RUGHU WR GHWHUPLQH
WKHLUSURFUHDWLYHVWDWXV
6WDWLVWLFDO DQDO\VHVZHUH FRQGXFWHGZLWK67$7,67,&$
7KH 6KDSLUR:LON WHVW ZDV XVHG IRU WKH DQDO\VLV RI QRUPDOO\
GLVWULEXWLRQ YDULDEOHV 0HDQV PHGLDQ VWDQGDUG GHYLDWLRQV DV
ZHOO DV PLQLPXP DQG PD[LPXP YDOXHV ZHUH FDOFXODWHG IRU
FRQWLQXRXV GDWD 7KH 0DQQ:KLWQH\ WHVW ZDV XVHG IRU JURXS
FRPSDULVRQV RI FRQWLQXRXV YDULDEOHV 7KH FKLVTXDUH WHVW IRU
LQGHSHQGHQFH ZDV XVHG IRU JURXS FRPSDULVRQV RI FDWHJRULFDO
YDULDEOHVpZDVFRQVLGHUHGDVVWDWLVWLFDOO\VLJQL¿FDQW
Results
$ WRWDO RI  SDWLHQWV SDUWLFLSDWHG  LQ WKH VWXG\ DQG DIWHU









FRQVHUYDWLYH WUHDWPHQW ZDV  GD\V 6' 7KH DYHUDJH
FRQFHQWUDWLRQ RI EK&* XSRQ DGPLVVLRQ ZDV  P,8
PO 6' ZLWK D PD[LPXP EK&* FRQFHQWUDWLRQ RI
 P,8PO 6'  8SRQ GLVFKDUJH WKH DYHUDJH
FRQFHQWUDWLRQ RI EK&* ZDV  P,8PO 6'
LQGLFDWLQJDGHFUHDVHRIEK&*E\6'LQUHODWLRQ
WR WKH PD[LPDO YDOXHV GXULQJ KRVSLWDOL]DWLRQ ,Q WKH PDMRULW\
RI SDWLHQWV LQWUDPXVFXODU PJ07; ZDV LQMHFWHG
LQ WKUHHGRVHVPJHDFK7KHFKDUDFWHULVWLFVRI WKHDQDO\]HG
JURXSV LQ WHUPV RI WKH OHQJWK RI KRVSLWDOL]DWLRQ DJH %0,
REVWHWULF KLVWRU\ EK&* FRQFHQWUDWLRQV DV ZHOO DV V\PSWRPV
XSRQDGPLVVLRQDUHSUHVHQWHGLQ7DEOH,7KHGHFUHDVHRIEK&*
WRXQGHWHFWDEOHOHYHOVWRRNDSSUR[LPDWHO\GD\V
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,QIRUPDWLRQ UHJDUGLQJ UHSURGXFWLYH SODQV DQG SRVVLEOH
SUHJQDQFLHVZDVREWDLQHGIURPSDWLHQWVGXULQJSDWLHQWIROORZ
XS YLVLWV WR WKH RXWSDWLHQW FOLQLF DVZHOO DV WKURXJK WHOHSKRQH
FRQWDFW7KUHHPRQWKVLQWRWKH07;WUHDWPHQWSDWLHQWVGHFLGHG
to enroll into an in vitro Iertili]ation SroJraP anG  oI tKeP JaYe 
EirtK to KealtK\ FKilGren 7KeVe SatientV Zere e[FlXGeG IroP 
IXrtKer VtXGieV 6XrJiFal SroFeGXreV Zere SerIorPeG in  otKer 
SatientV GXrinJ 07; tKeraS\ anG tKeVe SatientV Zere not inFlXGeG 
in IXrtKer VtXGieV eitKer $PonJ tKe  SatientV tKat TXali¿eG Ior 
IXrtKer VtatiVtiFal anal\ViV   GiG not attePSt to FonFeiYe 
aJain ZKereaV  SatientV attePSteG to FonFeiYe aJain anG  oI 
tKeP  JaYe EirtK to KealtK\ FKilGren 7Ke aYeraJe tiPe 
to SreJnanF\ ZaV  PontKV 6' ZitK tKe ¿rVt anG tKe 
laVt SreJnanF\ oFFXrrinJ aIter  anG  PontKV reVSeFtiYel\ 7Ke 
FXPXlatiYe SreJnanF\ rate aIter a PontK oEVerYation SerioG 
SoVttreatPent iV illXVtrateG in )iJXre  1ot a VinJle FaVe oI 
FonJenital EirtK GeIeFtV eVSeFiall\ neXral tXEe or FarGiaF ZaV 
oEVerYeG  7Ke aYeraJe EirtK ZeiJKt ZaV J 6' $ 
reFXrrenFe oI eFtoSiF SreJnanF\ ZaV not oEVerYeG in tKe VtXG\ 
SoSXlation 7Ke FKaraFteriVtiFV oI SatientV ZKo JaYe EirtK aV Zell 
aV tKoVe ZKo GeVSite e[SeFtationV GiG not FonFeiYe are SreVenteG 
in 7aEle ,,
Discussion
0etKotre[ate rePainV to Ee tKe PoVt FoPPonl\ XVeG aV Zell 
aV tKe PoVt eIIeFtiYe PeGiFation in FonVerYatiYe PanaJePent oI 
eFtoSiF SreJnanF\ 7KiV antaJoniVt oI IoliF aFiG GiVrXStV '1$ 
V\ntKeViV anG inKiEitV Fell SroliIeration 7Ke raSiGl\ GiYiGinJ 
troSKoElaVtiF tiVVXe iV eVSeFiall\ VenVitiYe to itV eIIeFtV 07; 
eIIeFt on otKer tiVVXeV VtronJl\ GeSenGV on tKe GoVe oI tKe GrXJ 7Ke 
PoVt FoPPonl\ enFoXntereG aGYerVe eIIeFtV oI 07; oYerGoVe 
inFlXGe inÀaPPation oI tKe PXFoVa oI tKe JaVtrointeVtinal traFt 
Eone ParroZ VXSSreVVion FonMXnFtiYitiV KeSatoto[iFit\ anG 
SKotoVenVitiYit\ 6\VtePiF aGPiniVtration oI tKe PeGiFation Pa\ 
Ee XVeG in a Yariet\ oI VFKePeV ,n oXr VtXG\ a VinJle GoVe oI 
 PJ 07; ZitKoXt aGGitional IoliF aFiG VXSSlePentation 
ZaV aGPiniVtereG ,n FaVeV ZitK inVXI¿Fient GroSV oI tKe EK&* 
FonFentration aGGitional GoVeV oI 07; Zere JiYen
7Ke eI¿FaF\ oI FonVerYatiYe 07; treatPent ZaV  
1oteZortK\ tKe treatPent ZaV eIIeFtiYe in SatientV ZitK KiJKer 
EK&* FonFentrationV Pa[iPal YalXe  P,8Pl 7Ke 
nXPEer oI GoVeV oI 07; anG tKe total GoVe aGPiniVtereG are 
SreVenteG in 7aEle ,,, reVSeFtiYel\ 6XFK a KiJK SerFentaJe oI 
treatPent VXFFeVV enFoXraJeV SK\ViFianV to attePSt aGPiniVterinJ 
Table  I .
$JH\HDUV 30.0  ±4.8
%0, NJP 22.6 ± 3.1
1H[W SUHJQDQF\
)LUVW SUHJQDQF\ 47 54%
1H[W SUHJQDQF\ 39 46%

































$EGRPLQDO SDLQ XSRQ DGPLVVLRQ 38 44.18%
9DJLQDO EOHHGLQJ XSRQ DGPLVVLRQ 67 77.9%
)UHH ÀXLG LQ WKH DEGRPHQ XSRQ 
DGPLVVLRQ 25  29.06%
0HDQ WLPH RI KRVSLWDOL]DWLRQ GD\V 9.7 ± 5.2
0HDQ EK&* XSRQ DGPLVVLRQ P,8PO 3569.8 ± 4552.9
0HDQ EK&* PD[ P,8PO 4809.3 ± 6079.4
0HDQ EK&* RQ GLVFKDUJH P,8PO 2234.7 ± 3202.4
0HDQ GHFUHDVH RI EK&* RQ GLVFKDUJH 
% 57.5 ± 25.1
 
Figure 1.      
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tKe PeGiFation in oXtSatient VettinJV ZKiFK ZoXlG ViJni¿Fantl\ 
FontriEXte to reGXFinJ KoVSitali]ation FoVtV 7KiV FoXrVe oI 
aFtion reTXireV SroSer traininJ oI tKe PeGiFal anG nXrVinJ VtaII 
at tKe oXtSatient FliniF aV Zell aV eVtaEliVKinJ VSeFi¿F Friteria 
reJarGinJ aGPiniVterinJ VXEVeTXent 07; GoVeV anG reFXrrent 
KoVSitali]ation ,t iV alVo neFeVVar\ to eGXFate SatientV anG tKeir 
IaPilieV Vo tKat tKe\ NnoZ KoZ to reaFt SroSerl\ in tKe FaVe oI 
ZorVeninJ FoPSlaintV
8nGer iGeal oSeratinJ FonGitionV a FXPXlatiYe SreJnanF\ 
rate ViPilar to tKe one IoXnG ZitK FonVerYatiYe 07; treatPent 
ZaV oEVerYeG 6XFK iGeal FonGitionV Fan oFFXr onl\ in FaVe oI 
PiFroVXrJiFal reanaVtoPoViV oI tKe IalloSian tXEeV aIter a Srior 
tXEal liJation ZKere tKe FXPXlatiYe SreJnanF\ rate inFlXGinJ 
eFtoSiF iV  >@ 
,n tKe VtXG\ SoSXlation VXEMeFteG to 07; tKeraS\ eFtoSiF 
SreJnanFieV Zere not oEVerYeG 8nIortXnatel\ PiFroVXrJerieV oI 
tKe IalloSian tXEeV XVinJ tKe laSaroVFoSiF teFKniTXe KaYe a Àat 
learninJ FXrYe ZKiFK Pa\ reVXlt in an inVXI¿FienF\ oI KiJKl\ 
traineG VtaII PePEerV eVSeFiall\ GXrinJ ePerJenF\ VitXationV
)ertilit\ eYalXation in SatientV aIter FonVerYatiYe treatPent 
ZaV KiJKl\ VatiVIaFtor\ 'XrinJ KoVSitali]ation no VtatiVtiFal 
ViJni¿FanFe in tKe aPoXnt oI tKe aGPiniVtereG 07; ZaV oEVerYeG 
EetZeen SatientV ZitK an attePSteG IaileG FonFeStion anG SatientV 
ZitK a VXFFeVVIXl SreJnanF\ anG GeliYer\ $lVo tKere Zere no 
ViJni¿Fant GiIIerenFeV EetZeen tKe rate oI GeFreaVe oI tKe EK&* 
FonFentration anG KoVSitali]ation lenJtK ± 3earVon
V Forrelation 
FoeI¿Fient r  ,t iV intereVtinJ to FonViGer eleYateG EK&* 
FonFentrationV on tKe EorGer oI VtatiVtiFal ViJni¿FanFe p  
in FaVe oI SatientV tKat VXFFeVVIXll\ FonFeiYeG 7KiV Pa\ Ee GXe 
to Jreater ElooG ÀoZ in tKe reJion oI tKe eFtoSiF SreJnanF\ tKXV 
IaFilitatinJ GrXJ aEVorStion into tKe tarJet tiVVXe
7Ke SreVenFe oI V\PStoPV XSon aGPiVVion ZaV on tKe 
EorGer oI ViJni¿FanFe p  ± ie aEGoPinal Sain anG YaJinal 
EleeGinJ ZKiFK ZaV Pore IreTXent in SatientV aEle to FonFeiYe 
VSontaneoXVl\ aIter tKe treatPent :e VXVSeFt tKat one oI tKe 
Pain IaFtorV in PaintaininJ IXrtKer Iertilit\ iV loFali]ation oI 
tKe eFtoSiF SreJnanF\ 6eYere ViJnV anG V\PStoPV Pa\ VXJJeVt 
an intraPXral VeFtion oI tKe IalloSian tXEe  $ltKoXJK a Jreater 
intenVit\ oI V\PStoPV PaNeV tKe GeFiVion Ior FonVerYatiYe 
treatPent Pore GiI¿FXlt 07; treatPent rePainV to Ee Eene¿Fial 
It is worth to mention the emotional trauma which 
accomSanies the GiaJnosis oI an ectoSic SreJnanc\ 7he GiaJnosis 
anG the IollowinJ JrieI ma\ haYe an imSact on the se[ualit\ oI 
the couSle $s conserYatiYe treatment is more time consuminJ 
Satients shoulG Ee oIIereG 7enGer /oYinJ &are 7/&
6tuGies haYe shown that 7/& ma\ haYe a siJni¿cant imSact 
on the chance oI a liYe Eirth rate in the ne[t SreJnanc\ >@ :e 
¿nG the SersSectiYe oI reJaininJ Iertilit\ esSeciall\ imSortant to 
these couSles




SDWLHQWV PHDQ SD PLQ PD[ SYDOXH
+RVSLWDOL]DWLRQ WLPH GD\V
1 15 11.7 4.1 6 18
0.06
2 10 8.4 3.7 4 15
)LUVW EK&* ,8PO
1 16 3185.6 2688.7 58 8414
0.12
2 10 1478 1261.6 76 3937
0D[ EK&* ,8PO
1 16 4404.6 3855.7 58 3425.5
0.06
2 10 1920.4 2194.6 118 1259
EK&* RQ GLVFKDUJH ,8PO
1 15 2011.9 1638 17 5279
0.08
2 10 1072.4 1715.6 38 5772
'HFUHDVH RI EK&* RQ 
GLVFKDUJH %
1 15 55.4 22.9 23.4 96.1
0.85
2 10 52.4 20.3 21.3 87.8
%0, NJP2
1 16 22.4 2.3 19.6 26.2
0.79
2 10 22.8 4.4 18 29.2
DJH \HDUV
1 16 28.9 4.6 22 39
0.17
2 10 31.4 4.5 30 40










50 PJ 1 6 7.0%
100 PJ 2 19 22.1%
150 PJ 3 42 48.8%
200PJ 4 6 7.0%
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It is also Yital to note that 07; theraS\ is the treatment oI 
choice in cases oI uniTue locali]ations oI an ectoSic SreJnanc\ 
such as cerYical anG uterine scar SreJnancies )inall\ in uncertain 
cases eIIort shoulG Ee unGertaNen to aYoiG ethical conseTuences 
oI the wronJ GiaJnosis anG Gecision
Conclusions
6\stemic conserYatiYe manaJement with methotre[ate is an 
eIIectiYe anG saIe Iorm oI treatinJ an ectoSic SreJnanc\ eYen in 
cases where Eh&* concentrations are Jreater than  mI8
ml 7he maMorit\ oI Satients can Ee successIull\ treateG without 
surJer\ anG thereIore ma\ eYen Ee treateG in outSatient settinJs
+iJh Iertilit\ inGeSenGent oI the sNills oI the oSerators 
anG access to laSaroscoSic techniTues can Ee maintaineG 
&onserYatiYe treatment Goes not increase the risN oI GeYeloSinJ 
a recurrent ectoSic SreJnanc\ 7reatment shoulG Ee oIIereG in 
warGs that SroYiGe hour surJical care 
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